Immuneering (IMRX) Total Liabilities (2020 - 2026)
Immuneering (IMRX) recorded Total Liabilities of $13.88 million in Q3 2026, up 6.1% from $13.08 million a year earlier and up 22.6% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Total Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Immuneering reported Total Liabilities of $13.5 million, up 19.2% from FY2024.
- Annual Total Liabilities has a five-year compound annual growth rate of -26.0% (FY2020 to FY2025).
- Across earlier years, Total Liabilities came in at $11.33 million in FY2024 (-5.7%), $12.01 million in FY2023 (-4.1%), $12.52 million in FY2022 (+16.7%) and $10.72 million in FY2021 (-82.4%).
- The Q3 2026 figure is the highest quarterly Total Liabilities since Q2 2021.
- On a year-over-year basis, Total Liabilities rose in five of the last eight quarters, with growth averaging 4.3%.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 105.2% in Q3 2022, against a decline of 90.4% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.32 million (Q2 2026), $8.29 million (Q1 2026) and $13.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 107.80 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 152.26 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 87.83 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 81.70 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 38.37 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 115.70 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 13.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.88 Mn |
| Jun 30, 2026 | 11.32 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Sep 30, 2025 | 13.08 Mn |
| Jun 30, 2025 | 11.12 Mn |
| Mar 31, 2025 | 8.84 Mn |
| Dec 31, 2024 | 11.33 Mn |
| Sep 30, 2024 | 10.84 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Mar 31, 2024 | 9.26 Mn |
| Dec 31, 2023 | 12.01 Mn |
| Sep 30, 2023 | 9.86 Mn |
| Jun 30, 2023 | 9.79 Mn |
| Mar 31, 2023 | 9.91 Mn |
| Dec 31, 2022 | 12.52 Mn |
| Sep 30, 2022 | 11.80 Mn |
| Jun 30, 2022 | 8.46 Mn |
| Mar 31, 2022 | 8.39 Mn |
| Dec 31, 2021 | 10.72 Mn |
API Access
Immuneering Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();